| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.004 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |